Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development

11 Sept 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Glioma Diagnosis and Treatment
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 31512029
DOI: 10.1007/s00280-019-03950-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical developmentPMID 31512029Read ↗

The Checkpoint Kinase 1 Inhibitor Prexasertib Induces Regression of Preclinical Models of Human NeuroblastomaSemantic proximity Read ↗

Inhibitors of cell cycle checkpoint target Wee1 kinase – a patent review (2003–2022)Semantic proximity Read ↗

Checkpoint kinase inhibitors: a review of the patent literatureSemantic proximity Read ↗

An update on PARP inhibitors—moving to the adjuvant settingSemantic proximity Read ↗

KRAS: Druggable at Last.Semantic proximity Read ↗

Investigational CHK1 inhibitors in early phase clinical trials for the treatment of cancerSemantic proximity Read ↗

Epi-drugs to fight cancer: From chemistry to cancer treatment, the road aheadSemantic proximity Read ↗

De-novo and acquired resistance to immune checkpoint targetingSemantic proximity Read ↗

Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1Semantic proximity Read ↗

A cell-based high-throughput screen to identify synergistic TRAIL sensitizersSemantic proximity Read ↗

Novel Checkpoint 1 InhibitorsSemantic proximity Read ↗

Do fourth-generation EGFR inhibitors showcase the future of kinase inhibitors?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.